These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 17100674)

  • 1. Comparison of a standard versus accelerated dosing regimen for D,L-sotalol for the treatment of atrial and ventricular dysrhythmias.
    Kim RJ; Juriansz GJ; Jones DR; Gerling BR; Holzberger PT; Greenberg ML
    Pacing Clin Electrophysiol; 2006 Nov; 29(11):1219-25. PubMed ID: 17100674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine.
    Hohnloser SH; van de Loo A; Baedeker F
    J Am Coll Cardiol; 1995 Oct; 26(4):852-8. PubMed ID: 7560608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic, pharmacodynamic, and safety evaluation of an accelerated dose titration regimen of sotalol in healthy middle-aged subjects.
    Barbey JT; Sale ME; Woosley RL; Shi J; Melikian AP; Hinderling PH
    Clin Pharmacol Ther; 1999 Jul; 66(1):91-9. PubMed ID: 10430114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of amiodarone versus sotalol in treatment of atrial fibrillation: a random controlled clinical study].
    Niu F; Huang CX; Jiang H; Yang B; Guo WL; Chen YX; Jin CR; Liu ZM
    Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):121-3. PubMed ID: 16620720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of paroxysmal atrial tachyarrhythmias--results of the SOPAT trial.
    Patten M; Maas R; Bauer P; Lüderitz B; Sonntag F; Dluzniewski M; Hatala R; Opolski G; Müller HW; Meinertz T;
    Eur Heart J; 2004 Aug; 25(16):1395-404. PubMed ID: 15321697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The comparison between the efficiency of different anti-arrhythmic agents in preventing postoperative atrial fibrillation after open heart surgery].
    Men EE; Yildirimtürk O; Tuğcu A; Aytekin V; Aytekin S
    Anadolu Kardiyol Derg; 2008 Jun; 8(3):206-12. PubMed ID: 18524727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative use of sotalol versus atenolol for atrial fibrillation after cardiac surgery.
    Sanjuán R; Blasco M; Carbonell N; Jordá A; Núñez J; Martínez-León J; Otero E
    Ann Thorac Surg; 2004 Mar; 77(3):838-43. PubMed ID: 14992883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sotalol reverses remodeled action potential in patients with chronic atrial fibrillation but does not prevent arrhythmia recurrence.
    Osaka T; Yamazaki M; Yokoyama E; Ito A; Kodama I
    J Cardiovasc Electrophysiol; 2004 Aug; 15(8):877-84. PubMed ID: 15333078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized comparison of amiodarone and class IC antiarrhythmic drugs to treat atrial fibrillation in patients paced for sinus node disease: the Prevention Investigation and Treatment: A Group for Observation and Research on Atrial arrhythmias (PITAGORA) trial.
    Gulizia M; Mangiameli S; Orazi S; Chiarandà G; Piccione G; Di Giovanni N; Colletti A; Pensabene O; Lisi F; Vasquez L; Grammatico A; Boriani G;
    Am Heart J; 2008 Jan; 155(1):100-7, 107.e1. PubMed ID: 18082498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical noncompliance of oral sotalol/magnesium for prophylactic treatment of atrial fibrillation after coronary artery bypass grafting.
    Mariscalco G; Cederlund B; Engström KG
    J Card Surg; 2007; 22(4):281-6. PubMed ID: 17661767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk prediction for adverse events during initiation of sotalol and dofetilide for the treatment of atrial fibrillation.
    Agusala K; Oesterle A; Kulkarni C; Caprio T; Subacius H; Passman R
    Pacing Clin Electrophysiol; 2015 Apr; 38(4):490-8. PubMed ID: 25626340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized double-blind trial of sotalol versus lignocaine in out-of-hospital refractory cardiac arrest due to ventricular tachyarrhythmia.
    Kovoor P; Love A; Hall J; Kruit R; Sadick N; Ho D; Adelstein BA; Ross DL
    Intern Med J; 2005 Sep; 35(9):518-25. PubMed ID: 16105152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of sotalol prescribing in a community hospital: opportunities for clinical pharmacist involvement.
    Finks SW; Rogers KC; Manguso AH
    Int J Pharm Pract; 2011 Aug; 19(4):281-6. PubMed ID: 21733016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing a safe intravenous sotalol dosing regimen.
    Somberg JC; Preston RA; Ranade V; Molnar J
    Am J Ther; 2010; 17(4):365-72. PubMed ID: 20562595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigating the effect of sotalol on the repolarization intervals in healthy young individuals.
    Couderc JP; Zhou M; Sarapa N; Zareba W
    J Electrocardiol; 2008; 41(6):595-602. PubMed ID: 18801493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practical regimen for amiodarone use in preventing postoperative atrial fibrillation.
    Zebis LR; Christensen TD; Thomsen HF; Mikkelsen MM; Folkersen L; Sørensen HT; Hjortdal VE
    Ann Thorac Surg; 2007 Apr; 83(4):1326-31. PubMed ID: 17383335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of daily dosing frequency on adherence to chronic medications among nonvalvular atrial fibrillation patients.
    Laliberté F; Nelson WW; Lefebvre P; Schein JR; Rondeau-Leclaire J; Duh MS
    Adv Ther; 2012 Aug; 29(8):675-90. PubMed ID: 22898791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ventricular proarrhythmic effects of atrial fibrillation are modulated by depolarization and repolarization anomalies in patients with left ventricular dysfunction.
    Lemola K; Khan R; Nattel S; Talajic M; Roy D; Guerra PG; Lemola S; Dubuc M; Thibault B; Macle L; Khairy P
    Pacing Clin Electrophysiol; 2009 Jan; 32(1):99-105. PubMed ID: 19140919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of antiarrhythmic efficacy of sotalol in various doses in patients with ventricular tachyarrhythmias].
    Luczak D; Dabrowski R; Szwed H; Gasior Z; Stanke A; Jasek S; Skrabucha B; Matar A; Kowalik I
    Pol Merkur Lekarski; 1997 Feb; 2(8):122-5. PubMed ID: 9538657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.